secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001822479-25-000050
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health Q3 net revenues +9.1% to $311M; adj EBITDA +12.2%; raises 2025 guidance
--------------------------------------------------------------------------------

- Q3 net revenues rose 9.1% to $311M; net income $48M ($0.17 diluted EPS) vs $17M ($0.06) a year ago.
- Adjusted EBITDA up 12.2% to $164M; Adjusted EPS $0.26 (+$0.09 YoY); constant-currency rev growth 8.0%.
- Nine-month 2025 net revenues $860M (+6.2%); net income $43M includes $34M pending EO settlement charge.
- 2025 guidance: reaffirms constant-currency revenue growth 4.5%-6.0%; raises adj EBITDA growth to 6.75%-7.75%.
- Sterigenics volumes strong; Nordion double-digit growth; Nelson Labs margin expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247925000050/0001822479-25-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247925000050/shc-20251104.htm
  HTML page:      https://secwatch.observer/filing/0001822479-25-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer